• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Abbott Opens State-of-the-Art Diabetes Care Manufacturing Facility in Kilkenny, Ireland

by Jasmine Pennic 11/18/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Copyright: Julien Behal

What You Should Know: 

– Abbott, a global healthcare leader, has officially opened its new global manufacturing center of excellence for Abbott’s diabetes care business in Kilkenny, Ireland. 

– Abbott’s FreeStyle Libre portfolio is the world’s leading continuous glucose monitoring system, helping more than 6 million people with diabetes across over 60 countries. 

Boosting Irish Economy and Manufacturing Capabilities

The Kilkenny facility is part of a €440 million investment by Abbott in Ireland, which also includes an expansion of its Donegal site. This investment will create over 1,000 jobs across both locations, boosting the Irish economy and strengthening the country’s manufacturing capabilities.

The new 30,000-square-meter facility in Kilkenny will produce FreeStyle Libre 3 sensors, the world’s smallest and most advanced continuous glucose monitoring (CGM) system. This technology helps people with diabetes manage their condition more effectively, improving their quality of life.

Commitment to Sustainability

Abbott’s Kilkenny facility was designed with sustainability in mind. It is fully electric, powered by renewable energy sources, and features rainwater harvesting systems. This commitment to environmental responsibility aligns with Abbott’s global sustainability goals.

Supporting STEM Education

In addition to its investment in manufacturing, Abbott is also supporting STEM education in Ireland through a new $100k grant to The Ireland Funds. This grant will fund scholarships for three 2024 Leaving Certificate graduates from local DEIS schools, enabling them to pursue third-level education in STEM subjects.

Expanding Manufacturing Footprint in Europe

Beyond Ireland, Abbott is further expanding its manufacturing capacity in Europe with an £85 million investment in its Witney facility in Oxfordshire, UK. This investment demonstrates Abbott’s commitment to meeting the growing global demand for its healthcare products.

“This is our latest commitment to providing innovative care and supporting people with diabetes to live healthier lives,” said Robert Ford, Chairman and CEO, Abbott. “The state-of-the-art Kilkenny facility will have the highest production of Libre sensors in the world to help meet the growing global demand for our world-leading2 FreeStyle Libre portfolio.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Abbott, Diabetes Management

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

 Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Selecting the Right EMR: A Practical Guide to Streamlining Your Practice and Enhancing Patient Care

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

CMS Finalizes New Interoperability and Prior Authorization Rule

CMS Proposes 2026 Physician Fee Schedule Rule: Boosting Primary Care, Cutting Waste, and Modernizing Payments

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

Beyond SaaS: How Agent as a Service is Transforming Healthcare Automation

New Strategies Needed: No Surprises Act and the Challenges for Payors with Provider Data Inaccuracies

Samsung Acquires Xealth to Accelerate Connected Care Vision

Samsung Acquires Xealth to Accelerate Connected Care Vision

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |